Vaccination With PD-L1 Peptide Against Multiple Myeloma
NCT03042793
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma
Interventions
BIOLOGICAL:
PD-L1 peptide vaccine
Sponsor
Lene Meldgaard Knudsen